NEW YORK, Oct. 30 – Motorola announced Monday it has completed development of its eSensor low-density clinical microarray, and will begin manufacturing this instrument in the second quarter of next year.

The company’s Clinical Micro Sensors business unit is making the sensors to do DNA testing for health care, agriculture, and environmental monitoring, as previously reported in GenomeWeb.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.